Cogstate Limited (CGS.AX)
AUD 1.3
(-4.07%)
AUD 1.3
(-4.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 8.31 Million AUD | 2.75% |
| 2023 | 5.3 Million USD | -48.85% |
| 2022 | 10.36 Million USD | 47.8% |
| 2021 | 7.01 Million AUD | 340.37% |
| 2020 | -2.91 Million AUD | 16.37% |
| 2019 | -3.48 Million AUD | -377.82% |
| 2018 | -730.36 Thousand AUD | 14.38% |
| 2017 | -853.06 Thousand AUD | -132.29% |
| 2016 | 2.64 Million AUD | 168.04% |
| 2015 | -3.88 Million AUD | -6.06% |
| 2014 | -3.66 Million AUD | -104.96% |
| 2013 | -1.78 Million AUD | -171.18% |
| 2012 | 2.5 Million AUD | 377.46% |
| 2011 | -904.39 Thousand AUD | -164.98% |
| 2010 | 1.39 Million AUD | 20.63% |
| 2009 | 1.15 Million AUD | 261.55% |
| 2008 | -714.2 Thousand AUD | 49.07% |
| 2007 | -1.4 Million AUD | -17.89% |
| 2006 | -1.18 Million AUD | 29.86% |
| 2005 | -1.69 Million AUD | 7.52% |
| 2004 | -1.83 Million AUD | -107.47% |
| 2003 | -883.88 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 5.16 Million AUD | 0.0% |
| 2024 FY | 8.31 Million AUD | 56.8% |
| 2024 Q2 | 3.07 Million AUD | 0.0% |
| 2023 Q2 | 90.86 Thousand AUD | 0.0% |
| 2023 FY | 5.3 Million USD | -48.85% |
| 2023 Q4 | 5.19 Million AUD | 0.0% |
| 2022 Q4 | 4.78 Million AUD | 0.0% |
| 2022 Q2 | 5.58 Million AUD | 0.0% |
| 2022 FY | 10.36 Million USD | 47.8% |
| 2021 Q4 | 7.36 Million AUD | 0.0% |
| 2021 Q2 | -619.93 Thousand AUD | 0.0% |
| 2021 FY | 7.01 Million AUD | 340.37% |
| 2020 Q2 | -3.01 Million AUD | 0.0% |
| 2020 Q4 | 1.14 Million AUD | 0.0% |
| 2020 FY | -2.91 Million AUD | 16.37% |
| 2019 FY | -3.48 Million AUD | -377.82% |
| 2019 Q4 | -740.24 Thousand AUD | 0.0% |
| 2018 FY | -730.36 Thousand AUD | 14.38% |
| 2017 FY | -853.06 Thousand AUD | -132.29% |
| 2016 FY | 2.64 Million AUD | 168.04% |
| 2015 FY | -3.88 Million AUD | -6.06% |
| 2014 FY | -3.66 Million AUD | -104.96% |
| 2013 Q3 | -489.3 Thousand AUD | 0.0% |
| 2013 FY | -1.78 Million AUD | -171.18% |
| 2013 Q1 | 612.99 Thousand AUD | 0.0% |
| 2013 Q2 | -489.3 Thousand AUD | -179.82% |
| 2013 Q4 | -489.3 Thousand AUD | 0.0% |
| 2012 Q2 | 612.99 Thousand AUD | 389.76% |
| 2012 FY | 2.5 Million AUD | 377.46% |
| 2012 Q3 | 612.99 Thousand AUD | 0.0% |
| 2012 Q1 | -211.55 Thousand AUD | 0.0% |
| 2012 Q4 | 612.99 Thousand AUD | 0.0% |
| 2011 Q1 | 409.4 Thousand AUD | 0.0% |
| 2011 Q2 | -211.55 Thousand AUD | -151.67% |
| 2011 FY | -904.39 Thousand AUD | -164.98% |
| 2011 Q3 | -211.55 Thousand AUD | 0.0% |
| 2011 Q4 | -211.55 Thousand AUD | 0.0% |
| 2010 Q4 | 409.4 Thousand AUD | 0.0% |
| 2010 Q2 | 409.4 Thousand AUD | 14.55% |
| 2010 Q3 | 409.4 Thousand AUD | 0.0% |
| 2010 FY | 1.39 Million AUD | 20.63% |
| 2010 Q1 | 357.4 Thousand AUD | 0.0% |
| 2009 Q4 | 357.4 Thousand AUD | 0.0% |
| 2009 Q2 | 357.4 Thousand AUD | 291.51% |
| 2009 Q1 | -186.62 Thousand AUD | 0.0% |
| 2009 Q3 | 357.4 Thousand AUD | 0.0% |
| 2009 FY | 1.15 Million AUD | 261.55% |
| 2008 Q2 | -186.62 Thousand AUD | 54.85% |
| 2008 FY | -714.2 Thousand AUD | 49.07% |
| 2008 Q4 | -186.62 Thousand AUD | 0.0% |
| 2008 Q3 | -186.62 Thousand AUD | 0.0% |
| 2008 Q1 | -413.31 Thousand AUD | 0.0% |
| 2007 FY | -1.4 Million AUD | -17.89% |
| 2007 Q2 | -413.31 Thousand AUD | -3.14% |
| 2007 Q4 | -413.31 Thousand AUD | 0.0% |
| 2007 Q3 | -413.31 Thousand AUD | 0.0% |
| 2007 Q1 | -400.72 Thousand AUD | 0.0% |
| 2006 Q2 | -400.72 Thousand AUD | 27.93% |
| 2006 FY | -1.18 Million AUD | 29.86% |
| 2006 Q4 | -400.72 Thousand AUD | 0.0% |
| 2006 Q3 | -400.72 Thousand AUD | 0.0% |
| 2006 Q1 | -556.03 Thousand AUD | 0.0% |
| 2005 Q4 | -556.03 Thousand AUD | 0.0% |
| 2005 Q2 | -556.03 Thousand AUD | -21.28% |
| 2005 FY | -1.69 Million AUD | 7.52% |
| 2005 Q1 | -458.45 Thousand AUD | 0.0% |
| 2005 Q3 | -556.03 Thousand AUD | 0.0% |
| 2004 Q2 | -458.45 Thousand AUD | -39.8% |
| 2004 Q1 | -327.94 Thousand AUD | 0.0% |
| 2004 Q3 | -458.45 Thousand AUD | 0.0% |
| 2004 Q4 | -458.45 Thousand AUD | 0.0% |
| 2004 FY | -1.83 Million AUD | -107.47% |
| 2003 Q4 | -327.94 Thousand AUD | 0.0% |
| 2003 Q3 | -327.94 Thousand AUD | 0.0% |
| 2003 Q2 | -327.94 Thousand AUD | 0.0% |
| 2003 FY | -883.88 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alcidion Group Limited | -8.41 Million AUD | 198.809% |
| Artrya Limited | -14 Million AUD | 159.406% |
| Beamtree Holdings Limited | -5.1 Million AUD | 262.882% |
| Careteq Limited | -2.66 Million AUD | 412.058% |
| Doctor Care Anywhere Group PLC | -10.04 Million AUD | 182.762% |
| Emyria Limited | -11.45 Million AUD | 172.599% |
| Global Health Limited | -1.31 Million AUD | 733.847% |
| HITIQ Limited | -3.2 Million AUD | 359.516% |
| Intelicare Holdings Limited | -2.25 Million AUD | 468.111% |
| ImExHS Limited | -4.19 Million AUD | 298.38% |
| Mach7 Technologies Limited | -7.97 Million AUD | 204.347% |
| MedAdvisor Limited | 792.13 Thousand AUD | -949.922% |
| Oakridge International Limited | -761.24 Thousand AUD | 1192.519% |
| Opyl Limited | -3.13 Million AUD | 365.68% |
| PainChek Limited | -8.3 Million AUD | 200.106% |
| Pro Medicus Limited | 82.79 Million AUD | 89.955% |
| Resonance Health Limited | 169.3 Thousand AUD | -4812.362% |
| Singular Health Group Ltd | -4.92 Million AUD | 268.879% |
| Total Brain Limited | -14.78 Million AUD | 156.267% |